News

SfRBM Stance on Immigration Executive Order

Through our affiliation with the Federation of American Societies for Experimental Biology (FASEB), SfRBM has signed onto a letter that was sent to the White House opposing the Executive Order that President Trump signed late last week.   SfRBM believes that scientific progress is compromised anytime that international collaboration, interaction and cooperation is limited in any manner. 

Read more »

— Published


Redox Biomarker Could Predict Progression of Epilepsy

Approximately 2.9 million people in the US suffer from epilepsy, according to the CDC. For patients living with this diagnosis and their doctors it is often difficult to predict the onset or progression of chronic seizures. Thanks to a newly published study from Drs. Manisha Patel and Li-Ping Liang of the University of Colorado, that may be changing.

Read more »

— Published


SfRBM to Host Redox Biology Symposia at EB 2018 Meeting

SFRBM is partnering with the American Physiological Society (APS) to host a symposium on "Redox Biology: A Unifying Theme in the Etiology of Human Diseases" at the 2018 Experimental Biology meeting in San Diego.

Read more »

— Published


Forman Selected as Lifetime Achievement Award Recipient

SFRBM's Senior Awards Committee has announced that the recipient of the 2016 Lifetime Achievement Award is Henry Jay Forman, Ph.D. of the University of Southern California.

Read more »

— Published


SfRBM Changes Name to Reflect Broader Mission

The Society for Free Radical Biology and Medicine is now the Society for Redox Biology and Medicine (SFRBM).

Read more »

— Published


New Treatment Method to Help Women Suffering From Fibrocystic Disease

A new patent has been issued for a method that uses the SOD-mimetic agent TEMPOL to treat fibrocystic disease of the breast (FD).

Read more »

— Published


Coenzyme Q10 may benefit patients with PAH

— Published